Physician

Allen I Wolfert, M.D.

According to 2025 Medicare claims, Allen Wolfert, M.D. (NPI: 1730165960) practices nephrology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is TEREDESAI MCCANN & ASSOCIATES PC (NPI: 1447289350; TIN: 251403041) and primary practice location at 15017-2894. Wolfert is affiliated with the Heritage Valley Healthcare Network ACO, LLC (ACO ID: A3730), participating under the MSSP model.

Wolfert's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 368 traditional Medicare patients, billed 906 HCPCS/CPT codes, and received $80,642 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,731 prescription claims across 406 beneficiaries totaling $278,841 in drug costs, led by Farxiga (Dapagliflozin Propanediol). Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $164,569 to $80,642. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $153,234 and ending at $278,841. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	413	1,900	$164,569
2016	392	1,925	$167,218
2017	369	1,865	$143,248
2018	376	1,810	$154,407
2019	459	2,049	$166,897
2020	461	1,484	$133,707
2021	445	1,084	$103,610
2022	367	819	$90,154
2023	365	1,021	$99,569
2024	368	906	$80,642

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	218	1,458	$153,234
2016	233	1,451	$234,320
2017	247	1,642	$281,865
2018	220	1,254	$186,184
2019	221	1,127	$124,822
2020	269	1,295	$205,092
2021	274	1,317	$174,465
2022	391	1,902	$297,837
2023	376	1,989	$339,360
2024	406	1,731	$278,841

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	52	99	$250
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	69	79	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	161	190	$85
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	56	128	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	179	214	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	82	3,479	$62,387
Jardiance	Empagliflozin	59	2,478	$46,177
Velphoro	Sucroferric Oxyhydroxide	11	690	$30,985
Veltassa	Patiromer Calcium Sorbitex	24	1,271	$17,873
Sevelamer Carbonate	Sevelamer Carbonate	42	1,640	$10,769

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$25	AKEBIA THERAPEUTICS INC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Allen I. Wolfert, M.D.?

Tedicare shows public-source Medicare data for Allen I. Wolfert, M.D. (NPI 1730165960), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allen I. Wolfert, M.D. have ACO affiliation data?

Allen I. Wolfert, M.D. is shown with ACO affiliation data for Heritage Valley Healthcare Network ACO, LLC (MSSP, ACO ID A3730).

What billing organization is linked to Allen I. Wolfert, M.D.?

Allen I. Wolfert, M.D. is linked to TEREDESAI MCCANN & ASSOCIATES PC (billing NPI 1447289350) in the available physician profile data.

Does Allen I. Wolfert, M.D. have Open Payments data?

Allen I. Wolfert, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.